Factors affecting the non-publication of clinical trials of prevalent urological cancer.
Abdulrahman AlhajahjehMajedah HmeidanAhmed A AbdulelahIsraa Al-NezaaFaris Al-AbbadiRyan W DobbsZahi Abdul SaterBashir Al Hussein Al AwamlhDavid I LeeMohammed ShahaitPublished in: World journal of urology (2024)
We found that almost one-half (47.2%) of all completed urologic oncology clinical trials are not published in a PubMed-indexed journal. This non-publication rate represents a significant loss of scientific knowledge and progress. We identified several key variables including sample size.